Global Urinary Incontinence Markets, 2018-2022 & 2023-2028: Companies Innovate Advertisements to Promote Urinary Incontinence Awareness as Disposables Dominate – ResearchAndMarkets.com

The “Global Urinary Incontinence Market (2023 Edition) – Analysis By Incontinence Type (Stress, Urge, Mixed, Others), Product Type, End-user, By Region, By Country: Market Size, Insights, Competition, Covid-19 Impact and Forecast (2023-2028)” report has been added to ResearchAndMarkets.com’s offering.

The Global Urinary Incontinence Market is expected to generate USD 21.1 billion by the end of 2028, up from USD 14,664.64 million in 2021. During the forecast period, 2023-2028, the Global Urinary Incontinence market is expected to expand at a CAGR of 8.12%.

The research is global in nature and covers a detailed analysis of the market in America (U.S., Canada, Rest of Americas), Europe (Germany, U.K, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), and the Middle East and Africa.

Additionally, the research report displays data including market size, yearly growth and potential analysis, the competitive study of market players, investment opportunities and strategic recommendations. The research study also looks at the market growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market evolution.

Urinary Incontinence is a global health issue that affects around 200 million people globally. The disorder may occur at any age due to several factors however it’s largely associated with the elderly population because of the high prevalence of UI in adults over age 65, who are the key end-user demographic of Urinary incontinence products.

Moreover, Urinary Incontinence is twice as prominent in Women than in Men. This is due to the fact that women’s reproductive health events, such as pregnancy, delivery, and menopause, alter the bladder, urethra, and other pelvic floor muscles that support these organs. Additionally, Diabetes, Obesity, Chronic lung infections and cough, neurological conditions and prostate disorders are risk factors associated with Urinary incontinence which is consequentially backing the market growth.

Companies are choosing interactive and engaging advertisements to battle social stigmas associated with the disease because people who experience, urinary incontinence are often subjected to stigma and psychological distress. Urinary incontinence is a condition that many individuals find embarrassing or afraid to discuss, which can result in a restraint to the flourishing growth of the market. Among product types, disposables hold the maximum share in the market.

The global market for urinary incontinence disposables is expected to grow in the coming years, driven by several factors such as the increasing prevalence of urinary incontinence and the growing demand for convenient and discreet solutions. Adult diapers, pads, and liners are among the most common types of urinary incontinence disposables, providing patients with comfort, confidence, and the ability to maintain their normal activities and routines.

The report provides a detailed overview of the Global Urinary Incontinence Market, which will assist industry consultants, equipment manufacturers, existing players looking for expansion opportunities, new players looking for opportunities, and other stakeholders in aligning their market-centric strategies with current and expected future trends.

Report Highlights

  • Impact Analysis of Macro Economic Factors on the Urinary Incontinence Market
  • Impact of COVID-19 on Urinary Incontinence Market
  • Global Urinary Incontinence Market: Ecosystem Analysis
  • Urinary Incontinence Clinical Trials
  • Prevalence of Urinary Incontinence in diabetic and non-diabetic patients

Global Urinary Incontinence Market: Historic and Forecast (2018-2028)

Global Urinary Incontinence Market Segmentation: By Incontinence Type

  • Global Urinary Incontinence Market, By Incontinence Type Overview
  • Global Urinary Incontinence Market Size, By Stress Incontinence, By Value, 2018H-2028F (USD Million & CAGR)
  • Global Urinary Incontinence Market Size, By Urge Incontinence, By Value, 2018H-2028F (USD Million & CAGR)
  • Global Urinary Incontinence Market Size, By Mixed Incontinence, By Value, 2018H-2028F (USD Million & CAGR)
  • Global Urinary Incontinence Market Size, By Other Incontinence, By Value, 2018H-2028F (USD Million & CAGR)

Global Urinary Incontinence Market Segmentation: By Product Type

  • Global Urinary Incontinence Market, By Product Type Overview
  • Global Urinary Incontinence Market Size, By Devices, By Value, 2018H-2028F (USD Million & CAGR)
  • Global Urinary Incontinence Market Size, By Disposables, By Value, 2018H-2028F (USD Million & CAGR)
  • Global Urinary Incontinence Market Size, By Other Product Types, By Value, 2018H-2028F (USD Million & CAGR)

Global Urinary Incontinence Market Segmentation: By End-User

  • Global Urinary Incontinence Market, By End-User Overview
  • Global Urinary Incontinence Market Size, By Hospitals, By Value, 2018H-2028F (USD Million & CAGR)
  • Global Urinary Incontinence Market Size, By Specialty Clinics, By Value, 2018H-2028F (USD Million & CAGR)
  • Global Urinary Incontinence Market Size, By Homecare, By Value, 2018H-2028F (USD Million & CAGR)

Competitive Positioning

  • Companies’ Product Positioning
  • Market Position Matrix
  • Market Share Analysis of the Urinary Incontinence Market

Company Profiles

  • Boston Scientific
  • Becton Dickinson & Company
  • Coloplast
  • Caldera Cook Group Inc.
  • Cook Group Inc.
  • Convatec Group Plc
  • Medtronic Plc
  • Teleflex Incorporated
  • Asahi Kasei Corporation
  • Berry Global
  • Cardinal Health Incorporated

For more information about this report visit https://www.researchandmarkets.com/r/t0wn9p

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”